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Neural crestIn Xenopus embryos, XMeis3 protein activity is required for normal hindbrain formation. Our results show
that XMeis3 protein knock down also causes a loss of primary neuron and neural crest cell lineages, without
altering expression of Zic, Sox or Pax3 genes. Knock down or inhibition of the Pax3, Zic1 or Zic5 protein
activities extinguishes embryonic expression of the XMeis3 gene, as well as triggering the loss of hindbrain,
neural crest and primary neuron cell fates. Ectopic XMeis3 expression can rescue the Zic knock down
phenotype. HoxD1 is an XMeis3 direct-target gene, and ectopic HoxD1 expression rescues cell fate losses in
either XMeis3 or Zic protein knock down embryos. FGF3 and FGF8 are direct target genes of XMeis3 protein
and their expression is lost in XMeis3 morphant embryos. In the genetic cascade controlling embryonic
neural cell speciﬁcation, XMeis3 lies below general-neuralizing, but upstream of FGF and regional-speciﬁc
genes. Thus, XMeis3 protein is positioned at a key regulatory point, simultaneously regulating multiple
neural cell fates during early vertebrate nervous system development.
© 2009 Elsevier Inc. All rights reserved.Introduction
In the developing Xenopus central nervous system (CNS), antero-
posterior (A–P) pattern is established by a multi-step inductive
process. In this proposed two-step model (Nieuwkoop, 1952), the
initial neural inducing signal is thought to specify anterior neuro-
ectodermal structures, such as cement gland and forebrain; this step is
referred to as “activation.” The subsequent caudalizing step is called
“transformation.” In this second inductive wave, anterior neuro-
ectodermal tissue is re-speciﬁed to more posterior fates, such as
midbrain, hindbrain, and spinal cord. A number of molecules have
been identiﬁed that participate in the “transformation” caudalization
process. Three secreted factors were shown to caudalize neural tissue
in whole Xenopus embryos or explants: retinoic acid, FGF, and
XWnt3a (Durston et al., 1989; Sive et al., 1990; Sharpe, 1991; Kolm
and Sive, 1995; Papalopulu and Kintner, 1996; Koide et al., 2001, Lamb
and Harland, 1995; Cox and Hemmati-Brivanlou, 1995; Holowacz and
Sokol, 1999; Ribisi et al., 2000; Domingos et al., 2001; Fletcher et al.,
2006; McGrew et al., 1995; McGrew et al., 1997).
XMeis3, a TALE-family homeobox protein is initially expressed as a
stripe in the presumptive neuroectoderm as early as mid-gastrulall rights reserved.stages, where it becomes localized in rhombomeres two, three, and
four, and the anterior spinal cord (Salzberg et al., 1999). Studies in
Xenopus and zebraﬁsh embryos demonstrate that Meis3 protein is
required for proper hindbrain formation (Dibner et al.; 2001, Dibner
et al., 2004; Waskiewicz et al., 2001; Vlachakis et al., 2001). In XMeis3
morphant Xenopus embryos, posterior expansion of the forebrain
occurs, with a concomitant loss of hindbrain cell fates; yet pan-neural
marker expression is unaltered (Dibner et al., 2001; Dibner et al.,
2004). Complementing these results, ectopic XMeis3 expression
caudalizes animal cap explants or embryos by inducing posterior
neural marker expression in the absence of pan-neural markers
(Salzberg et al., 1999). HoxD1 is a retinoic acid (RA) direct-response
gene (Kolm and Sive, 1995) that is also an XMeis3 direct-response
gene (Dibner et al., 2004). Ectopically expressed HoxD1 protein acts
downstream of XMeis3 protein and rescues the loss of hindbrain
phenotype in XMeis3 morphant embryos (Dibner et al., 2004). RA
signaling and XMeis3 protein act in concert to activate HoxD1
expression; HoxD1 is minimally expressed in the absence of either
factor.
XMeis3 is a transcription factor that can induce hindbrain cell fates
in a non-cell-autonomous manner. The knock down of endogenous
XMeis3 activity eliminates complete hindbrain formation, despite
being expressed in only r2–r4 (Dibner et al., 2001). XMeis3
caudalizing activity is absolutely dependent on the presence of FGF/
MAP kinase (MAPK) signaling (Ribisi et al., 2000, Aamar and Frank,
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inducing FGF3 transcription in the hindbrain (Aamar and Frank,
2004). FGF3 is required for hindbrain induction center formation in
zebraﬁsh (Maves et al., 2002, Walshe et al., 2002) and XMeis3 and
FGF3 are expressed in a similar temporal and overlapping regional
manner during Xenopus development (Lombardo et al., 1998). In
recombinant ectoderm explants, XMeis3 expressing tissue induced
mesoderm-independent convergent extension cell elongations in
adjacently juxtaposed neuralized explants. Elongated explants
expressed hindbrain, primary neuron and neural crest markers;
while forebrain marker expression was extinguished (Aamar and
Frank, 2004). These experiments suggest that XMeis3 protein acts
non-autonomously to establish a hindbrain induction center that
regulates early A–P cell fate in the developing CNS.
Since XMeis3 protein activity is required for proper cell fate
determination and morphogenesis in the hindbrain, we were curious
to determine if XMeis3 knockdown affected other early cell fate types
in the developing nervous system. Like the posterior CNS, neural crest
and primary neuron cells form in a similar locale and time window.
The signaling pathways required for posterior CNS formation, such as
FGF, canonical-Wnt, and RA are also necessary for neural crest and
primary neuron cell induction (Blumberg et al., 1997, Franco et al.,
1999, Sharpe and Goldstone, 1997, Hardcastle et al., 2000, Villanueva
et al., 2002, Shiotsugu et al., 2004).
This present study shows that in addition to the hindbrain, XMeis3
protein activity is essential for the proper formation of both primary
neuron and neural crest cells types. We have elucidated the hierarchy
of upstream and downstream transcription factor proteins regulating
XMeis3 induction of these multiple cell types. Neural-speciﬁc Zic and
Pax3 proteins lie upstream of XMeis3 to regulate its expression.
Ectopic XMeis3 protein rescues the loss of hindbrain, neural crest and
primary neurons in embryos depleted of Zic protein activity. The
HoxD1 protein acts downstream of XMeis3 protein; its ectopic
expression rescues these cell types in Zic or XMeis3 protein knocked
down embryos. FGF3 and FGF8 are XMeis3 direct target genes, and
their expression is reduced in XMeis3 morphant embryos. Ectopic FGF
expression can also rescue the XMeis3 morphant phenotype, though
partially. In the genetic cascade controlling early neural cell fates,
XMeis3 lies below neuralizing, but upstream of FGF3 and FGF8 and
other regional-speciﬁc genes. Thus, XMeis3 protein is located at a
central regulatory point, simultaneously regulating hindbrain, neural
crest and primary neuron cell fates during early vertebrate nervous
system development.
Materials and methods
Xenopus embryos and explants
Ovulation, in vitro fertilization, embryo and explant culture were
carried out as described (Re'em-Kalma et al., 1995). Embryos were
staged according to Nieuwkoop and Faber (1967).
RNA and morpholino oligonucleotide (MO) injections
Capped sense in vitro transcribed full-length mRNAs encoding
XMeis3 (Salzberg et al., 1999), Xngnr1 (Ma et al., 1996), Zic5
dominant-negative (DN) protein (Nakata et al., 2000), HoxD1 and
HoxD1-antimorph, (Dibner et al., 2004), FGF8a (Fletcher et al., 2006),
Pax3 and Zic1 (Monsoro-Burq et al., 2005) proteins were injected
into the animal hemisphere of one blastomere in embryos at the one
or two-cell stages. Zygotic FGF8a expression was driven by a CMV
based expression vector (Fletcher et al., 2006). Antisense morpholino
oligonucleotides (MOs) complementing the 5′ region of the XMeis3
(Dibner et al., 2001), Zic1 (Sato et al., 2005), and Pax3 (Monsoro-Burq
et al., 2005) were synthesized by Gene Tools, LLC; Philomath, Oregon,
U.S.A. Previously published studies using mismatch MOs showed thatthe XMeis3, Zic1 and Pax3 MOs all work speciﬁcally to alter cell fates
in Xenopus embryos (Dibner et al., 2001, Sato et al., 2005, Monsoro-
Burq et al., 2005).
In situ hybridization
Whole-mount in situ hybridization was carried out with digox-
igenin labeled probes (Harland 1991). Embryos were cultured to
neurula stages and subsequently ﬁxed for in situ hybridization. Probes
used were XMeis3 (Salzberg et al., 1999), Krox20 (Bradley et al.,
1992), N-tubulin (Ma et al., 1996), XMyt1 (Bellefroid et al., 1996), Slug
(Bonstein et al., 1998), FoxD3 (Sasai et al., 2001), Id3 (Light et al.,
2005), c-Myc (Bellmeyer et al., 2003), Pax3 (Monsoro-Burq et al.,
2005), FGF3 (Lombardo et al., 1998), XANF-1 (Zaraisky et al., 1995),
Zic R1/Zic1 (Mizuseki et al., 1998a), Zic2 (Nakata et al., 1998), Zic5
(Nakata et al., 2000), Sox2 (Mizuseki et al., 1998a) and SoxD (Mizuseki
et al., 1998b).
Semi-quantitative RT-PCR analysis
RT-PCR was performed as described (Wilson and Melton, 1994),
except that random hexamers (100 ng/reaction) were used for
reverse transcription. Primers used for PCR were: EF1a, Krox20
(Hemmati-Brivanlou and Melton 1994), HoxB3 (Hooiveld et al.,
1999), XMeis3 (Dibner et al., 2004), HoxD1 (Kolm and Sive, 1995),
SoxD (Kato et al., 1999), Zic1 and Zic2 (Nakata et al., 1998), FoxD3
(Sasai et al., 2001), FGF3 and FGF8 (Domingos et al., 2001), Slug, n-
tubulin, Xngnr1, NeuroD and nrp1 (Harland Lab database).
XMeis3-GR inducible protein
RNA encoding the XMeis3-GR (glutocorticoid receptor) inducible
fusion protein (Dibner et al., 2004) was injected at the one-cell stage.
Animal cap (AC) explants were removed at blastula stages for culture.
At late blastula stages, cyclohexamide (CHX, 5 μM) was added. After
1.5 hours, dexamethasone (DEX, 1 μM) was added, at gastrula stages
10–10.25. Explants were cultured until stage 12 and total RNA was
isolated for RT-PCR analysis.
Results
XMeis3 protein is required for primary neuron and neural crest
formation
Our initial studies showed that n-tubulin expression in the
hindbrain and spinal cord regions was inhibited by ectopic XMeis3
antimorph protein activity (Dibner et al., 2001). In XMeis3
antimorph phenotypes, HoxB9 expression was fairly normal,
suggesting that the spinal cord is preserved, but primary neurogen-
esis is impaired (Dibner et al., 2001). To further elucidate this point,
embryos were injected with the XMeis3 MO in one blastomere at
the two-cell stage. In XMeis3 morphant neurula stage embryos,
there was a marked reduction in primary neurogenic gene
expression. Similar to the XMeis3 antimorph protein, n-tubulin
expression is strongly inhibited by the XMeis3 MO (Fig. 1A). N-
tubulin serves as a marker for primary neuron differentiation, and
its inhibition demonstrates that initial primary neuron formation in
the spinal cord and hindbrain (including the most anterior
trigeminal in r2) is highly disrupted (Fig. 1A). In addition,
expression of upstream pro-neural genes, such as NeuroD, Xngnr1
(not shown), and XMyt1 was highly inhibited (Fig. 1B). At later
tadpole stages, we examined XMeis3 morphant embryos for
expression of the tanabin/nestin and Islet-1 (Xisl-1) genes, which
mark hindbrain derived cranial neurons (Hemmati-Brivanlou et al.,
1992, Bardine et al., 2009). In XMeis3 morphant embryos, Xisl-1 and
tanabin/nestin expression was highly reduced in the head,
Fig. 1. XMeis3 knockdown inhibits primary neuron and neural crest marker expression, but does not inhibit expression levels of Sox and Zic family genes or upstream regulators of
neural crest. Two-cell stage albino embryos were injected unilaterally into the animal hemisphere of one blastomere with 10–20 ng of XMeis3 MO. All embryos are injected on the
right side, viewed dorsally and are oriented anterior (top), posterior (bottom); the red arrows mark the dorsal midline in A–D. (A) N-tubulin expression is inhibited in 91% of the
embryos (n=100/110). (B) XMyt1 expression is inhibited in 100% of the embryos (n=12/12). (C) FoxD3 expression is inhibited in 83% of the embryos (n=116/139). (D) Slug
expression is inhibited in 75% of the embryos (n=70/93). (E) Zic1 expression is normal in 96% of the embryos (n=26/27). (F) Zic2 expression is normal in 96% of the embryos
(n=23/24). (G) Zic5 expression is normal in 91% of the embryos (n=91/100). (H) Sox2 expression is normal in 95% of the embryos (n=20/21). (I) SoxD expression is normal in
96% of the embryos (n=26/27).(J) Pax3 expression is normal in 85% of the embryos (n=28/33). 15% of the embryos had minor expression reductions. (K) c-Myc expression is
normal in 83% of the embryos (n=25/30). 17% of the embryos hadminor expression reductions. (L) Id3 expression is normal in 84% of the embryos (n=32/38). 16% of the embryos
had minor expression reductions. In all experiments, Krox20 expression inhibition is assayed as a positive control for XMeis3 MO activity. In the described experiments, Krox20
expression is inhibited in 94% of the embryos (n=190/202). Expression of the proneural gene (not shown), Xngnr1 is inhibited in 77% of the embryos (n=48/62). For Sox, Zic, Pax3,
c-Myc and Id3, overall gene expression levels are quite normal despite morphological perturbations on the XMeis3 MO injected side.
52 Y.E. Gutkovich et al. / Developmental Biology 338 (2010) 50–62suggesting that the cranial nerve V, VII, IX and X cell fates are also
eliminated (Sup. Figs. 1A, B). We further addressed expression of
more upstream genes regulating neurogenesis. Gene expression of
the Zic and Sox families of neuralizing transcription factors was
examined in XMeis3 morphant embryos. These genes lie upstream
of pro-neural genes in regulating primary neuron cell formation
(Sasai, 1998, Chitnis, 1999). We found that Zic (Zic1, Zic2, Zic3 (not
shown) and Zic5) and Sox (Sox2, and SoxD) family gene expression
levels were unchanged in XMeis3 morphant embryos (Figs. 1E–I).
These results suggest that XMeis3 could be positioned in the middle
of the cascade controlling differentiation of primary neurons during
early neurogenesis; XMeis3 protein could lie downstream to the
more generally expressed neurogenic genes, but upstream to
regionally-speciﬁc expressed pro-neural genes.XMeis3 protein activity is required for primary neuron cell
formation in embryos, thus we also investigated the effect of
XMeis3 knockdown on neural crest cell formation, since both primary
neurons and neural crest are induced in the neural folds-plate regions
by identical signaling pathways in a similar temporal manner. In
XMeis3morphant embryos, expression of the neural crest speciﬁc Slug
and FoxD3markers was highly inhibited (Figs. 1C, D). In later tadpole
stages, neural crest derived melanocyte cells are severely depleted in
morphant embryos (Sup. Fig. 1C). In contrast, expression of more
upstream neural crest regulators, such as Pax3, c-myc and id3 is
unaltered in morphant embryos (Figs. 1J–L). Zic1 and Zic5 expression
levels were also unaltered in morphant embryos (Figs. 1E, G); these
proteins are required for neural crest formation in Xenopus embryos
(Nakata et al., 2000; Sato et al., 2005). As a control for XMeis3 MO
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2001). As determined by both RT-PCR (not shown) and in situ
hybridization to embryos, FoxD3 (Sup. Fig. 2A); Krox20 and n-tubulin
(not shown) gene expression is rescued by co-injection of the XMeis3
mRNA in XMeis3 morphants.
The HoxD1 protein lies downstream of XMeis3 in regulating multiple
cell fates in the developing nervous system
Our previous studies showed thatHoxD1 is an XMeis3 direct-target
gene (Dibner et al., 2004). We also showed that ectopic HoxD1
expression rescued hindbrain cell fates in XMeis3 morphant embryos
(Dibner et al., 2004). To conﬁrm that HoxD1 acts downstream of
XMeis3 in neural crest or primary neuron cell fate formation, we
injected HoxD1 antimorph encoding RNA into embryos. Ectopic
HoxD1 antimorph protein expression strongly inhibits hindbrainFig. 2. Ectopic expression of the HoxD1 antimorph protein knockdown inhibits primary neur
embryos were injected unilaterally into the animal hemisphere of one blastomere with 100 p
side, viewed dorsally and are oriented anterior (top), posterior (bottom). (a) Krox20 express
in 97% of the embryos (n=57/59). (c) Slug expression is inhibited in 85% of the embryos (n=
expression is normal in 100% of the embryos (n=16/16). (f) Zic1 expression is normal in 93
embryos (n=16/16). (B) Ectopic HoxD1 expression rescues n-tubulin expression in XMeis3 m
embryo. (b) 18 ng XMeis3 MO, n-tubulin expression (right side) was inhibited in 68% (n=2
highly rescued (left side) in 75% (n=12) of the embryos.(Dibner et al., 2004), as well as primary neuron (n-tubulin) and neural
crest (Slug, FoxD3) marker expression (Fig. 2Aa–d). Conﬁrming
previously published results (Dibner et al., 2004), XMeis3 expres-
sion was unaltered in all examined HoxD1 antimorph embryos
(not shown, n=16). Similar to XMeis3 morphants, Sox2 (not
shown), Pax3 and Zic1 expression levels were not reduced in
HoxD1 antimorph embryos (Fig. 2Ae–f). To determine that HoxD1
is a downstream mediator of XMeis3 activity for the speciﬁcation
of primary neuron or neural crest cell fates, we injected HoxD1
encoding RNA into embryos knocked down for XMeis3 protein.
Ectopic HoxD1 protein expression rescued primary neuron (com-
pare Fig. 2Bb to Bc) and neural crest (not shown) cell formation in
XMeis3 morphant embryos. Interestingly, neural crest marker
expression was only rescued under experimental conditions that
did not rescue primary neuron or hindbrain marker expression
(not shown).on and neural crest markers in addition to hindbrain markers. (A) Two-cell stage albino
g of RNA encoding the HoxD1 antimorph protein. All embryos are injected on the right
ion is inhibited in 87% of the embryos (n=83/95). (b) N-tubulin expression is inhibited
44/52). (d) FoxD3 expression is inhibited in 87% of the embryos (n=52/60). (e) Pax3
% of the embryos (n=13/14). XMeis3 expression (not shown) is normal in 100% of the
orphant embryos. The dashed red lines mark the dorsal midline. (a) Uninjected control
2) of the embryos. (c) 18 ng XMeis3 MO, 0.8 ng HoxD1 RNA, n-tubulin expression was
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fates in the developing nervous system
XMeis3 could be located at a key regulatory point, acting
downstream of neuralizing Zic proteins and acting upstream of the
speciﬁc genes regulating primary neuron or neural crest cell fates. Zic
proteins are excellent candidates to be acting upstream of XMeis3 in
regulating neural crest, primary neuron and/or hindbrain cell fates.
Ectopic expression of Zic proteins in Xenopus embryos and AC
explants activated expression of posterior neural, primary neuron
and neural crest marker genes (Mizuseki et al., 1998a, Nakata et al.,
1998, Kuo et al., 1998, Nakata et al., 2000, Sasai et al., 2001). In
addition, knock down of Zic protein activities, using either the Zic5
dominant-negative (DN) protein or the Zic1 MO inhibited neural
crest formation in Xenopus embryos (Nakata et al., 2000; Sato et al.,
2005).
To address Zic/XMeis3 epistasis, we examined the phenotype of
Zic protein inhibition. Embryos were injected with either RNA
encoding the Zic5 DN protein or the Zic1 MO. We used these two
complementary inhibitory approaches, since the Zic1 MO could be a
more speciﬁc tool than the Zic5 DN protein, which may inhibit
activity of all endogenous Zic proteins (Nakata et al., 2000). For the
Zic5 DN embryos, posterior neural marker expression was examined
by both whole mount in situ hybridization and semi-quantitative RT-Fig. 3. Inhibition of Zic protein activity by ectopic expression of the Zic5 dominant-negative (
expression. (A) Two-cell stage albino embryos were injected unilaterally into the animal he
are injected on the right side, viewed dorsally and are oriented anterior (top), posterior (bo
expression is inhibited in 91% of the embryos (n=74/81). (c) N-tubulin expression is inhib
embryos (n=37/43). (B) One-cell stage embryos were injected in the animal hemisphere w
pools of seven neurula stage 16 embryos in each group. Semi-quantitative RT-PCR analysis
EF1α. In all shown experiments, EF1α serves as a control for quantitating RNA levels in
embryos (not shown in this experiment). (C) One-cell stage embryos were injected in the a
RNA was isolated from pools of eight gastrula stage 11.5 embryos in each group. Semi-quant
performed on total RNA isolated from normal embryos (not shown in this experiment). (D) O
of Zic1MO. RNAwas isolated from pools of ten neurula stage 18 embryos in each group. Sem
n-tubulin, Slug, FoxD3, SoxD, and EF1α. -RT-PCR was performed on total RNA isolated fromPCR in gastrula (Fig. 3C) and neurula stage embryos (Figs. 3A, B). In
addition to the anticipated loss of neural crest markers (Slug and
FoxD3, Figs. 3Ab, d, B), Krox20 expression in the hindbrain (Fig. 3B,
Fig. 4Fb), and expression of primary neuron markers such as Xngnr1
(Fig. 3B), NeuroD (not shown), and n-tubulin (Figs. 3Ac, B) were also
inhibited in Zic5 DN phenotype embryos. Interestingly, XMeis3
expression was also eliminated from hindbrain and anterior spinal
cord in the Zic5 DN protein injected embryos (Figs. 3Aa, B). As in
XMeis3 morphant embryos, Zic5 DN protein expression also
eliminated HoxD1 expression in gastrula stage embryos (Fig. 3C).
This is the ﬁrst observation of any upstream neurogenic gene that
regulates embryonic XMeis3 expression, suggesting that early
expressed neuralizing Zic gene family proteins may be required for
the regional-speciﬁc transcriptional activation of XMeis3 and HoxD1
genes in the embryo.
Similar to the Zic5 DN protein, Zic1 morphant embryos also have
highly reduced expression of hindbrain (Krox20, HoxB3), primary
neuron (NeuroD, n-tubulin) and neural crest markers (slug, FoxD3);
pan-neural marker (SoxD, Nrp1) expression is normal (Figs. 3D, 4C).
Marker inhibition is dose dependent, with hindbrain and primary
neuronmarkers beingmore sensitive to lower Zic1MO concentrations
than the neural crest markers, whose expressionwas only inhibited at
the highest injected Zic1 MO levels (Fig. 3D). Similar to the Zic5 DN
phenotype, gastrula stage expression of XMeis3 (not shown) andDN) protein or the Zic1 MO inhibits hindbrain, primary neuron, and neural crest marker
misphere of one blastomere with 200 pg of Zic5 DN protein encoding RNA. All embryos
ttom). (a) XMeis3 expression is inhibited in 84% of the embryos (n=42/50). (b) FoxD3
ited in 83% of the embryos (n=91/109). (d) Slug expression is inhibited in 86% of the
ith 0.4 ng of Zic5 dominant-negative protein encoding RNA. Total RNAwas isolated from
was performed with the markers: XMeis3, Krox20, n-tubulin, Xngnr1, Slug, FoxD3, and
the different samples. -RT-PCR was performed on total RNA isolated from normal
nimal hemisphere with 0.4 ng of Zic5 dominant-negative protein encoding RNA. Total
itative RT-PCR analysis was performed with the markers: HoxD1 and EF1α. -RT-PCR was
ne-cell stage embryos were injected in the animal hemisphere with 25, 30, 35, or 40 ng
i-quantitative RT-PCR analysis was performed with the markers: Krox20, HoxB3, NeuroD,
normal embryos.
Fig. 4. Ectopic XMeis3 expression rescues the Zic protein knock down phenotypes. (A) One-cell stage embryos were separately injected in the animal hemisphere with 20 ng of Zic1
MO and/or 0.2 ng of XMeis3 RNA. At neurula stage 16, embryos were scored for neural fold inhibition and ﬁxed. 71% of the Zic1 morphant embryos (n=21) had severely inhibited
neural fold closure. In the Zic1 MO/XMeis3 coinjected group, only 23% of the embryos (n=40) had severely inhibited neural fold closure. Only those embryos with rescued neural
folds were taken for Krox20 expression analysis. (a) In the control group, 6/6 embryos stained positive for Krox20 expression; (b) In the Zic1MO group, 1/6 stained positively. (c, d)
In the elongated embryos from the Zic1MO/XMeis3 injected group, 5/7 stained positively. (B) One-cell stage embryos were separately injected in the animal hemisphere with 20 ng
of Zic1MO and/or 0.2 ng of XMeis3 RNA. Total RNAwas isolated from pools of seven gastrula stage 11 embryos in each group. Semi-quantitative RT-PCR analysis was performed with
the markers: HoxD1 and EF1α. -RT-PCR was performed (not shown) on total RNA isolated from normal embryos. (C) One-cell stage embryos were separately injected in the animal
hemisphere with 20 or 30 ng of Zic1 MO and/or 0.7 or 1.4 ng of XMeis3 RNA. Total RNA was isolated from pools of six to twelve neurula stage 16 embryos in each group. Semi-
quantitative RT-PCR analysis was performed with the markers: Krox20, n-tubulin, Nrp1, and EF1α. Nrp1 is a panneural marker. -RT-PCR was performed on total RNA isolated from
normal embryos. (D) One-cell stage embryos were separately injected in the animal hemisphere with 45 ng of Zic1 MO and/or 0.9 ng of XMeis3 RNA. Total RNA was isolated from
pools of six late neurula stage 20 embryos in each group. Semi-quantitative RT-PCR analysis was performed with the markers: Krox20, FoxD1, and EF1α. -RT-PCR was performed on
total RNA isolated from normal embryos. (E) One-cell stage embryos were separately injected in the animal hemisphere with 20 ng of Zic1MO and/or 0.1–0.2 ng of XMeis3 RNA. (a)
At neurula stage 16, embryoswere scored for neural fold inhibition and ﬁxed. (b) 89% of the Zic1morphant embryos (n=18) had extremely inhibited neural fold closure. (c, d) In the
Zic1 MO/XMeis3 coinjected group, 58% of the embryos (n=57) had fairly normal neural fold closure, versus 11% in the Zic1 morphant group (b). (F) Two-cell stage albino embryos
were injected unilaterally into the animal hemisphere of one blastomere with 200 pg of Zic5 DN protein and/or 0.4 ng of HoxD1 or 0.5 ng of XMeis3 encoding RNA. Signiﬁcant
morphological rescue was also observed in the co-injected embryos. All embryos are oriented, right side/injected side, dorsal view, anterior (top), posterior (bottom). The dashed
red lines mark the dorsal midline. (a) At neurula stage 17, embryos were scored for Krox20 expression. (b) Krox20 was expressed in only 7.5% of the Zic5 DN injected embryos. (c)
Krox20 was expressed highly in 38% of the XMeis3/Zic5 DN co-injected embryos (n=50). (d) Krox20 was expressed highly in 20% of the HoxD1/Zic5 DN co-injected embryos
(n=50). (G) One-cell stage embryos were separately injected in the animal hemisphere with 0.35 ng of Zic5 DN RNA and/or 0.3 ng of XMeis3 RNA. (a) At neurula stage 17, embryos
were scored for n-tubulin expression (b). In the Zic5 DN injected group, 69% of the embryos had medium to undetectable levels of n-tubulin expression (n=21). (c, d) In the Zic5 DN/
XMeis3 injected group 79% of the embryos had medium to strong levels of n-tubulin expression (n=24). In this same experiment, inhibition of Krox20 expression by the Zic5 DN
protein was also rescued by ectopic XMeis3 protein levels (not shown).
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control for Zic1 MO speciﬁcity, we have repeated rescue experiments
(Sato et al., 2005). Similar to neural crest markers, Krox20 and n-
tubulin gene expression is rescued by co-injection of the Zic1mRNA in
Zic1 morphants (Sup. Figs. 2B, C).To determine Zic1/XMeis3 epistasis, XMeis3 encoding RNA was
ectopically expressed in Zic1 morphant embryos. The Zic1 protein
knock down phenotypes are rescued by either ectopic XMeis3
(Figs. 4A–D) or HoxD1 (not shown) protein expression, however not
all markers to the same extent. As expected, Nrp1 (pan-neural)
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almost all rescue experiments, the Krox20 hindbrain marker is re-
expressed at high levels (Figs. 4A, C, D). In some experiments, ectopic
XMeis3 protein strongly rescues hindbrain, with strong - intermediate
rescue of primary neurons (Fig. 4C). At a lower frequency, neural crest
cells are rescued (Fig. 4D), with or sometimes without rescue of
primary neurons. Interestingly, hindbrain is usually the “default”
rescue with consistent varying degrees of rescue penetrance for
primary neuron or neural crest markers. We often observe that
ectopic XMeis3 activity in wild type AC explants and embryos triggers
high levels of hindbrain marker (Krox20) expression that can be
associated with either an increase or a decrease in neural crest or
primary neuron marker expression. In embryos and AC explants
expressing relatively low ectopic XMeis3 RNA levels, there is often a
more efﬁcient activation of neural crest versus hindbrain marker
expression (Sup. Figs. 3A–C); neural crest markers are induced at low
mRNA XMeis3 concentrations that do not induce ectopic Krox20
expression. However, when XMeis3 mRNA concentrations are in-
creased in AC explants or embryos, neural crest marker expression
can be suppressed with the concomitant increase of Krox20
expression (Sup. Figs. 3B–E); primary neuron marker expression
may increase or decrease (Sup. Figs. 3D, E). In any given experiment,
the different location and concentration of XMeis3 protein in could
bias for or against speciﬁc cell types. In cases of high XMeis3 levels, the
preference to induce hindbrain cell fates may be favored; at low
XMeis3 levels, neural crest cell fates are favored. Thus, these
experiments reveal the differential effects of XMeis3 activity in
regulating posterior neural cell fates.
In a complementary manner and similar to the Zic1 MO (Fig. 3D),
higher concentrations of XMeis3 MO are required to inhibit neural
crest marker expression versus hindbrain or primary neurons (Sup.
Fig. 3F). Like the Zic1 MO, the XMeis3 MO maximally inhibits the
hindbrain marker Krox20 at the lowest concentrations, the primary
neuron marker, n-tubulin is moderately affected at lower concentra-
tions, and the neural crest marker slug is optimally affected at higher
concentrations. These results reveal that the inductions of these
various posterior neural cell fates possess different threshold
responses to XMeis3 protein (see Discussion).
Similar results were seen for embryos co-injected with Zic5 DN
and XMeis3 encoding RNAs. In Zic5 knockdown embryos, ectopic
XMeis3 expression robustly rescues Krox20 (compare Fig. 4Fb to
Fc) and n-tubulin (compare Fig. 4Gb to Gc–d) and slug to a lesser
extent (not shown). The rescue of neural crest markers only occurs
in conditions in which Krox20 or n-tubulin expression was not
rescued, suggesting that XMeis3 under certain conditions can
induce regional speciﬁcity on the Zic5 knocked down phenotype.
In general, XMeis3 rescue of the Zic5 DN phenotype was less
efﬁcient than for the Zic1 morphant phenotype. Due to its more
general inhibitory activity for all Zic proteins, the Zic5 DN tended to
give a more potent phenotype that was more difﬁcult for rescue by
ectopic XMeis3 expression.
Phenotypically, Zic1 morphant and Zic5 DN embryos (not shown)
also undergo signiﬁcantly reduced neural convergence-extension cell
movements, with a subsequent inhibition of neural folding (compare
Fig. 4Ea control, to Fig. 4Eb Zic1 morphant). The ectopic expression of
XMeis3 protein dramatically restores these morphogenetic cell
movements in about 50% of the Zic1 morphant embryos (Fig. 4Eb
Zic1 morphant to the Fig. 4Ec–d Zic1 MO/XMeis3 co-injected). This
observation concurs with our previous ﬁndings, that XMeis3 protein
activity is crucial to regulate correct neural convergent-extension
morphogenetic cell movements in the posterior neural plate (Aamar
and Frank, 2004).
In the Zic1 morphant phenotype, XMeis3 (not shown) and HoxD1
(Fig. 4B) expression is inhibited. We wanted to determine if ectopic
HoxD1 protein could rescue the Zic knock down phenotype. In
embryos separately co-injected with the Zic5 DN protein and HoxD1RNA, there is signiﬁcant rescue of Krox20 (compare Fig. 4Fb to Fd) and
n-tubulin expression (not shown); however, it was difﬁcult to detect
signiﬁcant rescue of neural crest markers under these experimental
conditions. Also, supporting these observations, co-injection of
XMeis3 RNA rescues HoxD1 expression in Zic1 morphant embryos
(Fig. 4B).
Our observations in embryos were also complemented by
experiments performed in caudalized AC explants. AC explants are
caudalized by the coinjection of wnt3a and noggin protein encoding
RNAs (Monsoro-Burq et al., 2005). The combination of these
neuralizing and caudalizing activities efﬁciently activates expression
of the Krox20, HoxB3, FoxD3, and n-tubulin markers (Figs. 5A, B).
Expression of Zic family mRNAs, such as Zic1 and Zic2 is also robustly
induced in this assay (Fig. 5B). Expression of XMeis3 transcripts is
also highly induced in these neuralized/caudalized AC explants
(Elkouby and Frank unpublished data). When these caudalized
explants are coinjected with either the Zic5 DN RNA or the Zic1 MO,
there is a striking inhibition of posterior neural marker expression
(Figs. 5A, B), despite the expression of the pan-neural Zic1, Zic2 and
SoxD genes (Fig. 5B). Presumably, the caudalizing Zic protein activity
in the untreated neuralized/caudalized explants is blocked by the
Zic5 DN protein or the translational blocking Zic1 MO. Similar to
whole embryos, ectopic expression of XMeis3 protein signiﬁcantly
restores expression of hindbrain (Krox20, HoxB3) and primary
neuron markers in AC explants when Zic protein activities are
knocked down (Figs. 5A, B); similar to embryos, rescue of neural
crest marker expression rescue was weak. However, XMeis3
expression did rescue Zic protein knockdown of neural crest marker
expression in experiments in which the wnt3a/noggin concentration
exclusively activated neural crest markers, but none of the other
posterior neural markers (data not shown).
XMeis3 also lies downstream of Pax3 protein
Pax3 is another early expressed gene that was shown to interact
with Zic proteins in regulating neural crest formation (Monsoro-
Burq et al., 2005; Sato et al., 2005). In XMeis3 morphant embryos
Pax3 expression was unaltered, suggesting that Pax3 could lie
upstream to XMeis3 (Fig. 2F). To clarify if XMeis3 lies downstream
to Pax3, XMeis3 expression was examined in Pax3 morphant
embryos. In Pax3 morphant embryos, XMeis3 expression was
strongly reduced (Fig. 6A). It was previously shown that Pax3
morphant embryos lacked neural crest cells (Monsoro-Burq et al.,
2005; Sato et al., 2005). However, in addition to loss of neural crest
marker expression, slug (Fig. 6B) and FoxD3 (not shown), there is
also a sharp reduction in n-tubulin and Krox20 expression in Pax3
morphant embryos (Figs. 6C, D). As in XMeis3 morphants, Pax3
morphant embryos expressed fairly normal levels of the c-myc
gene, which is required for neural crest speciﬁcation, as well as the
pan-neural expressed Sox2 gene (Figs. 6E, F). Thus, similar to Zic
and Meis3 protein knockdown, Pax3 protein knockdown also
eliminated hindbrain and primary neuron cell fates, suggesting
that Pax3 lies upstream of XMeis3 to regulate all three of these cell
fates. Unlike the Zic5 DN protein and Zic1 MO, ectopic XMeis3
expression could not rescue the Pax3 morphant phenotype (not
shown). Apparently, some cue is lacking in Pax3 morphant embryos
that is required for XMeis3 protein activity. As a control for Pax3
MO speciﬁcity, we have repeated rescue experiments (Monsoro-
Burq et al., 2005). Krox20 and FoxD3 gene expression is rescued by
co-injection of the Pax3 mRNA in Pax3 morphants (Sup. Figs. 2D, E).
These observations in embryos were complemented by experi-
ments performed in caudalized AC explants. AC explants are
caudalized by the coinjection of Pax3 and Zic1 protein encoding
mRNAs (Monsoro-Burq et al., 2005; Sato et al., 2005). The combina-
tion of these two protein activities efﬁciently activates expression of
the HoxB3, n-tubulin, and Slugmarkers (Fig. 5C). Previous studies had
Fig. 5. Inhibition of XMeis3 or Zic protein activities inhibits posterior neural marker expression in neuralized animal cap explants. (A) One-cell stage embryos were separately
injected in the animal hemisphere with a pool of 10 pg Wnt3a RNA/10 pg noggin RNA and/or 0.3 ng of Zic5 DN RNA and/or 0.2 ng of XMeis3 RNA. Animal cap (AC) explants were
removed at blastula stages 8–9. Explants and embryos were cultured to neurula stage 18, and total RNA was isolated from pools of sixteen AC explants in each group and ﬁve control
embryos (CE). RT-PCR analysis was performed with the markers: Krox20, HoxB3, n-tubulin, FoxD3 and EF1α. -RT-PCR was performed on total RNA isolated from control embryos.
Note the strong level of Zic5 DN protein inhibition of posterior neural marker expression and their rescue by XMeis3 expression. (B) One-cell stage embryos were separately injected
in the animal hemisphere with a pool of 10 pg Wnt3a RNA/10 pg noggin RNA and/or 27 ng of Zic1 MO and/or 0.4 ng of XMeis3 RNA. Animal cap (AC) explants were removed at
blastula stages 8–9. Explants and embryos were cultured to neurula stage 18, and total RNA was isolated from pools of eleven to eighteen AC explants in each group and ﬁve control
embryos (CE). RT-PCR analysis was performed with the markers: Krox20, n-tubulin, FoxD3, Zic1, Zic2, SoxD and EF1α. -RT-PCR was performed on total RNA isolated from normal
embryos. Note the strong level of Zic1 MO inhibition of posterior neural marker expression and their rescue by XMeis3 expression. (C) One-cell stage embryos were separately
injected in the animal hemisphere with a pool of 0.15 ng Zic1 RNA/0.15 ng Pax3 RNA and/or 25 ng of XMeis3MO. Animal cap explants were removed at blastula stages 8–9. Explants
and embryos were cultured to neurula stage 17, and total RNA was isolated from pools of ﬁfteen AC explants in each group and ﬁve control embryos (CE). RT-PCR analysis was
performed with the markers: Krox20, HoxB3, n-tubulin, Slug, and EF1α. -RT-PCR was performed on total RNA isolated from normal embryos. Note the strong level of XMeis3 MO
inhibition of posterior marker expression in the far right row.
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expression. When these caudalized explants are coinjected with the
XMeis3 MO, there is a striking inhibition of posterior neural marker
expression (Fig. 5C), despite the expression of endogenous XMeis3
mRNA in the AC explants (not shown). In explants, XMeis3
knockdown mimics the same inhibitory effects seen downstream to
Pax3 and Zic1 proteins in the embryo.
The Xngnr1 protein acts downstream of XMeis3 to speciﬁcally regulate
primary neuron cell fates
HoxD1 lies downstream of XMeis3 to induce multiple cell fates,
yet some other target proteins must lie further downstream of
XMeis3/HoxD1 to regulate speciﬁc neural cell lineages. Xngnr1 is
one of the earliest regionally expressed pro-neural genes regulating
primary neuron formation (Ma et al., 1996). We were curious to
determine if ectopic Xngnr1 protein levels could rescue primary
neuron cell fates in XMeis3 morphant embryos in which n-tubulin
expression is eliminated (Figs. 7A, B). Xngnr1 encoding RNA was
co-injected along with the XMeis3 MO. Expression of Xngnr1
encoding RNA alone induces n-tubulin expression on the injected
side of normal embryos (Ma et al., 1996; Fig. 7C). In Xngnr1/
XMeis3 MO co-injected embryos, n-tubulin is expressed at high
ectopic levels (Fig. 7D). Thus XMeis3 protein activity is not
required for Xngnr1 protein to activate n-tubulin transcription.
This effect is speciﬁc for primary neurons, since Krox20 (hindbrain)
expression is not rescued in the Xngnr1 injected embryos (not
shown). It appears that Xngnr1 is a stronger activator of n-tubulin
expression in embryos lacking XMeis3 activity versus controls
(compare Figs. 7C, D). Hence, the proper balance of XMeis3 activity
in the embryo may be required to direct cells to their various cell
fates, but in XMeis3 morphants, cells are driven to a speciﬁc cell-
fate direction by ectopic expression of a lineage-speciﬁc down-
stream activator such as Xngnr1.FGF3/8 are direct target genes acting downstream of XMeis3 protein
Our previous studies showed that XMeis3 activated FGF3 and FGF8
gene expression in early neurula stage AC explants, and that XMeis3
protein cannot caudalize in the absence of FGF signaling (Ribisi et al.,
2000, Aamar and Frank 2004). To determine if FGF3 and FGF8 are
direct target genes of the XMeis3 protein, we injected RNA encoding
an inducible XMeis3-GR fusion protein (Dibner et al., 2004). When AC
explants were pre-treated with CHX before DEX induction of XMeis3
protein activity, FGF3 and FGF8 mRNAs were still robustly induced
(Fig. 8A). As a control, we show that the induction of Krox20
expression is strongly inhibited by CHX treatment. Complementing
this result, we also found that FGF3 (Fig. 8B) and FGF8 (not shown)
expression in early-mid neurula stage embryos was severely inhibited
in XMeis3 morphant embryos. We have not seen a reciprocal effect on
XMeis3 expression by manipulating FGF levels in embryos or
explants. Neither ectopic expression of FGF nor its knockdown
signiﬁcantly modulates XMeis3 expression in explants or embryos
(not shown). To determine if FGF proteins act downstream to XMeis3
protein, XMeis3 morphant embryos were co-injected with CMV-
vector driving zygotic FGF8a or FGF3 expression. By examining
embryo morphology or neural marker expression by whole mount
in situ hybridization, we detected a signiﬁcant rescue of the XMeis3
morphant phenotype. Ectopic FGF8a expression rescued neural plate
folding and convergent extension in XMeis3 morphant embryos (Fig.
8C). Interestingly, expression of FGF8a strongly inhibited expanded
expression of the anterior XANF-1 marker in morphants (Fig. 8D). N-
tubulin expression was robustly enhanced in embryos expressing
FGF8a and partially rescued in morphant embryos expressing FGF8a
(Fig. 8E). FGF3 was also able to inhibit and rescue XANF-1 and n-
tubulin respectively, in addition to a partial rescue of the neural crest
marker, FoxD3 (not shown) in XMeis3 morphants. Yet, under these
experimental conditions, hindbrain markers were not signiﬁcantly
rescued. These results strengthen our previous observations (Ribisi et
Fig. 6. Pax3 knockdown inhibits primary neuron and hindbrain markers in addition to neural crest marker expression. Two-cell stage albino embryos were injected unilaterally into
the animal hemisphere of one blastomere with 20 ng of Pax3MO. All embryos are viewed dorsally and are oriented anterior (top), posterior (bottom). In each embryo trio panel, the
control embryo is on the left, Pax3mis-match MO injected (mm) center, and the Pax3 MO (MO) on the right. The red arrows mark the dorsal midline. (A) In the shown experiment,
XMeis3 expression was inhibited in 76% of the Pax3 morphant embryos (n=21). Expression was normal in uninjected controls (91%, n=23) and embryos injected with a 5 bp mm
Pax3MO (90%, n=22). In all experiments, XMeis3 expression is inhibited in 83% of the morphant embryos (n=38). (B) In the shown experiment, Slug expression is inhibited in 95%
of the morphant embryos (n=21). Slug expression was normal in uninjected controls (85%, n=20) and embryos injected with a 5-bp mm Pax3 MO (76%, n=17). In all
experiments, Slug expression is inhibited in 93% of the morphant embryos (n=55). FoxD3 expression is inhibited in 79% of the morphant embryos (n=33, not shown). (C) In the
shown experiment, n-tubulin expression was inhibited in 78% of the embryos (n=18) Expression was normal in uninjected controls (81%, n=21) and embryos injected with a 5-bp
mm Pax3 MO (75%, n=24). In all experiments, n-tubulin expression is inhibited in 90% of the morphant embryos (n=58). (D) In the shown experiment, Krox20 expression is
inhibited in 95% of the morphant embryos (n=21). Expression was normal in uninjected controls (76%, n=21) and embryos injected with a 5-bp mm Pax3MO (74%, n=19). In all
experiments, Krox20 expression is inhibited in 93% of the morphant embryos (n=133). (E) In the shown experiment, c-myc expression was normal in morphant embryos (86%,
n=22). Expression was normal in uninjected controls (88%, n=24) and embryos injected with a 5 bp mm Pax3 MO (77%, n=22). In all experiments, c-Myc expression is
normal in 92% of the Pax3 morphant embryos (n=38). (F) Sox2 expression was normal in morphant embryos (76%, n=23). Expression was normal in uninjected controls (91%,
n=23) and embryos injected with a 5-bp mm Pax3 MO (82%, n=22).
Fig. 7. Ectopic Xngnr1 expression rescues n-tubulin expression in XMeis3 morphant embryos. Two-cell stage albino embryos were co-injected unilaterally into the animal
hemisphere of one blastomere with 10–20 ng of XMeis3 MO and/or 0.8 ng of RNA encoding the Xngnr1 protein. All embryos are injected on the right side, viewed dorsally and are
oriented anterior (top), posterior (bottom). Whole mount in situ hybridization of the n-tub marker is shown. A. N-tubulin expression is normal in 100% of the uninjected control
embryos (n=22/22). B. N-tubulin expression is highly inhibited in 92% of the XMeis3 morphant embryos (n=11/12). As a control for XMeis3 MO activity, Krox20 expression was
examined (not shown); its expression was inhibited in 90% of the embryos (n=9/10). (C) Injection of Xngnr1 RNA induces ectopic n-tubulin expression in 87% of the control
embryos (n=20/23). (D) Injection of Xngnr1 RNA induces high ectopic n-tubulin expression levels in 100% of the XMeis3 morphant embryos (n=18/18). Krox20 was not
ectopically activated in these embryos (not shown).
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Fig. 8. FGF3/8 genes lie downstream to XMeis3 protein. (A) FGF3 and FGF8 are XMeis3 direct-target genes. One-cell stage embryos were injected in the animal hemisphere with
250 pg of inducible XMeis3-GR encoding RNA. In all experimental groups, eighteen animal cap explants were respectively removed from embryos at blastula stages 8–9. Explants
from each group were grown in cyclohexamide and/or dexamethasone (materials and methods) to stage 12 and total RNA was isolated. RT-PCR analysis was performed with the
markers: Krox20, FGF3, FGF8 and EF1α. For controls, RT-PCR and -RT-PCR was performed on total RNA isolated from ﬁve normal embryos. (B) XMeis3 knockdown inhibits FGF3
expression. Two-cell stage embryos were injected unilaterally into the animal hemisphere of one blastomere with 7–10 ng of XMeis3MO. All embryos are viewed dorsally and are
oriented anterior (top), posterior (bottom). As designated by the red arrows, in comparison to control embryos (left panel) FGF3 expression in the hindbrain is inhibited on the
injected side of the shown embryos (right panel). FGF3 expression was inhibited in 77% of the XMeis3 morphant embryos (n=177). (C) Ectopic FGF8a expression rescues neural
folding and convergent extension in XMeis3 morphant embryos. One-cell stage embryos were injected unilaterally into the animal hemisphere of one blastomere with 19 ng of
XMeis3 MO followed by injection of 15 pg of a CMV-vector driving zygotic FGF8a expression. Embryos were cultured until stage 18, and ﬁxed for analysis. All embryos are viewed
dorsally and are oriented anterior (top), posterior (bottom). Left panel: uninjected control, center panel: XMeis3 morphant, a shorter embryo with poor neural folding, right panel:
XMeis3 MO+FGF8a, the embryo is longer with more distinct neural folds. (D) One-cell stage embryos were separately injected in the animal hemisphere with 15 ng of XMeis3MO
and/or 15–30 pg of FGF8a encoding DNA vector. At neurula stage 16, embryos were ﬁxed and examined for expression of the anterior neural marker. The red arrows emphasize the
XANF-1 expression region. 82% of themorphant embryos (n=28) had expanded XANF-1 expression. In the XMeis3MO/FGF8a coinjected group, only 20% of the embryos (n=44) had
expanded XANF-1 expression, whereas most embryos had fairly normal expression levels. (E) One-cell stage embryos were separately injected in the animal hemisphere with 18 ng
of XMeis3MO and/or 20–30 pg of FGF8a encoding DNA vector. At neurula stage 17, embryos were ﬁxed and examined for expression of the n-tubulinmarker. 96% of the morphant
embryos (n=26) had highly reduced n-tubulin expression. In the XMeis3MO/FGF8a coinjected group, 93% of the embryos (n=55) had rescued-ectopic levels of n-tubulin
expression, similar to embryos injected with the FGF8a vector alone.
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downstream to XMeis3 protein in the process of neural A–P
patterning.
Discussion
Meis3 protein is required for induction of primary neuron and neural
crest fates
In this study, we examined the pathway hierarchy in which
XMeis3 protein regulates multiple cell fate speciﬁcation in the
developing nervous system (Sup. Fig. 4B—model). In neurula
embryos, the knock down of XMeis3 was shown to eliminate primary
neuron and neural crest cell fates in addition to the hindbrain.
Furthermore, hindbrain derived neurons and neural crest derived
melanocytes were also severely depleted in later stage XMeis3
morphant tadpoles. In XMeis3 morphant embryos, transcription of a
battery of proneural and downstream target genes that are requiredfor primary neuron induction, such as Xngnr1, NeuroD, XMyt1 and n-
tubulin was inhibited. Ectopic Xngnr1 protein can rescue n-tubulin
expression in XMeis3 morphant embryos, suggesting that it lies
downstream to XMeis3 protein. In this study, we show a novel role for
Zic1 and Pax3 proteins in posterior neural patterning. In addition to
their role in regulating neural crest speciﬁcation (Monsoro-Burq et al.,
2005; Sato et al., 2005), we now show that Zic1 and Pax3 proteins
have a previously undiscovered more general role in regulating both
hindbrain and primary neuron cell fates (Sup. Fig. 4—model).
In XMeis3 morphant embryos, the pre-migratory neural crest
markers, such as slug and FoxD3were eliminated, whereas expression
of the c-myc and Id3 genes was not altered. C-myc and id3, which lie
upstream to slug and FoxD3 are also expressed in more anterior
neural fold regions that are not fated for neural crest. These genes are
likely players in a parallel upstream XMeis3-independent component
of neural crest speciﬁcation. Interestingly, the expression of other
upstream regulators of neural crest induction, such as Pax3 and Msx1
(not shown), is also unaltered in XMeis3 morphant embryos. Pax3
60 Y.E. Gutkovich et al. / Developmental Biology 338 (2010) 50–62and Msx1 lie upstream of XMeis3 in regulating neural crest induction
(Monsoro-Burq et al., 2005; Sato et al., 2005). These proteins are
thought to interact with Zic1 to induce neural crest (Sato et al., 2005),
thus supporting the observation that XMeis3 is epistatically posi-
tioned between neurogenic and cell speciﬁc genes. XMeis3 protein is
positioned at a central regulatory point that is crucial for inducing
primary neuron, neural crest and hindbrain cell types.
Zic1 and Pax3 proteins lie upstream to XMeis3 in regulating multiple
posterior neural cell fates
The proteins regulating XMeis3 expression therefore give a clue as
to the initial upstream pathways regulating early cell fate decisions in
the nervous system. Sox and Zic family transcription factors have been
associated as neuralizing proteins lying downstream of BMP signaling
antagonism in the neural induction process (Sasai, 1998). Indeed Sox
and Zic family genes are expressed at quite normal levels in XMeis3
morphant embryos. Zic proteins have the potential to induce posterior
neural, primary neuron and neural crest cell fates in Xenopus explants
(Mizuseki et al., 1998a, Nakata et al., 1998, Kuo et al., 1998, Nakata et
al., 2000, Sato et al., 2005). The knock down of Zic protein activity was
also shown to inhibit neural crest formation in Xenopus embryos
(Nakata et al., 2000, Sato et al., 2005). In addition to the disruption of
neural crest, we show that embryos knocked down by Zic5 DN protein
or the Zic1 MO lose primary neuron and hindbrain cell types. XMeis3
expression was also eliminated in these embryos. To prove that
XMeis3 lies downstream of Zic protein activity, ectopic XMeis3
protein was expressed along with the Zic5 DN protein or Zic1 MO. In
these embryos, the Zic protein loss-of-function phenotype was
eliminated and hindbrain, primary neuron, and neural crest cell
fates were rescued to varying degrees by ectopic XMeis3 protein.
Additionally, the loss of neural folds phenotype typical of Zic1
morphant embryos was signiﬁcantly rescued in XMeis3-expressing
embryos.
Hindbrain, primary neuron and neural crest cell-types do not
appear to be equivalent in their XMeis3/Zic1 epistasis. In XMeis3
morphant embryos, hindbrain genes are the most sensitive to
changing XMeis3 levels, with primary neuron and neural crest cell
fates typically requiring a stronger morphant phenotype (Sup. Fig.
3F). A similar observation was seen in Zic1 morphant embryos (Fig.
3D). The knockdown of Zic1 was originally shown to prevent neural
crest formation (Monsoro-Burq et al., 2005; Sato et al., 2005).
However, we have found that similar to XMeis3 morphants, neural
crest cells are consistently lost at higher concentrations of Zic1 MO
than those required to eliminate either hindbrain or primary neuron
cell fates. This observation could be a direct result of residual XMeis3
expression levels present in the weaker Zic1 morphant phenotype. In
AC explants and embryos, neural crest markers are only induced at
very low ectopic XMeis3 expression levels that do not efﬁciently
induce hindbrain or primary neurons (Sups. Fig. 3A–C). At typically
higher XMeis3 injection levels, hindbrain cell fates are the dominant
default state for XMeis3 activity, with markers like Krox20 or HoxB3,
being induced in the absence or presence of neural inducers (Dibner
et al., 2001). In embryos injected with very high ectopic levels of
XMeis3 mRNA, we have observed a high ectopic Krox20 expression
with reductions in neural crest marker expression (Sup. Figs. 3D, E).
Thus, higher ectopic levels of XMeis3 preferentially drive hindbrain
formation, but intermediate and lower level XMeis3 levels are
permissive and required for primary neuron and neural crest
formation. The results of XMeis3 rescue in Zic1 morphants also
support this idea, since Krox20 was always the easiest gene to rescue
followed by n-tubulin and lastly slug/FoxD3. At the time of neural
caudalization, in late gastrula/early neurula stages, cells in the
posterior neural plate and neural crest region are all in very close
proximity. Our previous studies show that XMeis3 acts both
autonomously and non-autonomously to induce hindbrain, primaryneuron and neural crest cell fates (Aamar and Frank, 2004,
unpublished observations). Thus the early events specifying individ-
ual cell fates downstream of XMeis3 activity are not necessarily
equivalent. For example, neural crest fates appear to occur in cells
with lower XMeis3 activity, whereas hindbrain fates are induced by
high XMeis3 activity. XMeis3 is expressed in these earlier stages in
presumptive hindbrain cells and thus this could drive their fate;
whereas, in contrast, perhaps the non-autonomous “weaker” XMeis3
activity is what drives the induction of the adjacent neural crest cells
that do not express XMeis3. In this manner the balance between
“stronger” autonomous and “weaker” non-autonomous activities may
drive differential cell fate speciﬁcations. Future experiments utilizing
our recombinant explant assay system (Aamar and Frank, 2004)
should elucidate this point.
It is still not clear if the role of Zic1 protein is to exclusively regulate
XMeis3 expression levels. Alternatively, the combination of Zic1 and
XMeis3 protein concentration ratios in a given cell could possibly
determine differential cell fate outcomes. These genes have non-
identical but partially overlapping expression patterns during
development. The question of XMeis3 and Zic1 interactions in
determining neural cell fates, either in a cell-autonomous or non-
autonomousmanner can also be addressed in embryos or explants co-
expressing varying ectopic levels of each protein.
Previous studies suggested that Pax3 and Zic proteins interact to
regulate neural crest formation (Monsoro-Burq et al., 2005; Sato et al.,
2005). In this study, we signiﬁcantly advanced this concept by
showing that elimination of Pax3 or Zic protein activities prevents
proper XMeis3 expression in the embryo which triggers the loss of
hindbrain, primary neuron, and neural crest cell fates. Re-addition of
XMeis3 to embryos knocked down for Zic, but not Pax3 activities
rescues these phenotypes. Thus, upstream Pax3 and Zic proteins
control XMeis3 gene expression, which then acts downstream to
trigger multiple cell fate decisions in the nervous system.
HoxD1 protein lies downstream to XMeis3 regulating posterior neural
cell fate speciﬁcation
We previously showed that the HoxD1 protein was an XMeis3
direct-target gene (Dibner et al., 2004).We demonstrated that ectopic
HoxD1 expression rescued hindbrain marker expression (Krox20 and
HoxB3) in XMeis3 morphant embryos. Similar to XMeis3 knock
down, we show that ectopic HoxD1 antimorph protein expression
also prevented primary neuron and neural crest induction. We now
show that ectopic HoxD1 expression also rescues primary neuron and
neural crest marker expression in XMeis3 morphant embryos. Thus
HoxD1 protein is positioned downstream of XMeis3 in the cascade
regulating embryonic nervous system cell fate decisions. The
knockdown of the Hox paralogous group 1 (PG1) genes (Hox A1-B1-
D1) in Xenopus caused severe defects in hindbrain and neural crest
formation, but primary neuron cell formation was not examined in
this study (McNulty et al., 2005). Knockdown of XMeis3 activity
eliminates embryonic HoxD1 and HoxB1 expression (Dibner et al.,
2001, Dibner et al., 2004). Presumably HoxA1 expression is also
inhibited, but this still has to be examined. The HoxD1 antimorph
protein and XMeis3 MO may therefore induce a similar global HOX
PG1 knock down phenotype. Thus by regulating Hox PG1 gene family
expression, XMeis3 can direct these early neural cell fate decisions.
Meis3 protein integrates multiple caudalizing signaling pathways
What still needs to be discerned is how XMeis3 or Hox PG1
proteins can simultaneously induce speciﬁcity in these different
cellular regions. For example, we show that Xngnr1 lies downstream
of XMeis3, where it exclusively induces primary neurons and not
neural crest or hindbrain cell fates when ectopically expressed in
XMeis3 morphant embryos. Therefore the question arises as to how
61Y.E. Gutkovich et al. / Developmental Biology 338 (2010) 50–62regional-speciﬁc expression of genes like Xngnr1/NeuroD, slug/FoxD3,
or Krox20/HoxB3 occurs, thus enabling correct cell fate speciﬁcation.
The basis of these variant responses could reﬂect innate differential
competence potentials in the cells bordering XMeis3 expressing cells.
XMeis3 is expressed as early as gastrula stages in a distinct stripe
mapping to the presumptive hindbrain region (Salzberg et al., 1999).
XMeis3 expression is regionally restricted, yet the effects of its
knockdown are widespread, altering cell fates in the hindbrain,
spinal cord and neural crest regions. Many of these cells do not have
overlapping XMeis3 expression domains. One possible explanation
for this observation is that XMeis3 protein could induce these
different cell fates in a non-cell autonomous manner (Aamar and
Frank, 2004). These results suggest that XMeis3 expressing cells form
a very early neural patterning induction center, responsible for
speciﬁcation of hindbrain, primary neuron, and neural crest cell fates.
At late gastrula stages, when this center would be active, the target
cells would all be clustered in fairly close proximity. XMeis3
responsive cells in the embryo may have a competence “history” of
higher or lower canonical-Wnt, RA, or FGF signaling levels, which
when coupled to a permissive signal emanating from XMeis3
expressing cells may enable a pre-built-in bias in cell fate decision
to occur. Thus identical signaling pathways, utilizing differentially
expressed Wnt or FGF ligands, or RA receptors could be utilized
downstream of XMeis3 in distinct embryonic regions to caudalize
cells to variant cell fates along the A–P axis.
The signaling pathways required for posterior CNS formation,
such as FGF, canonical-Wnt, and RA are also necessary for neural
crest and primary neuron cell fate induction (Blumberg et al., 1997,
Franco et al., 1999, Sharpe and Goldstone, 1997, Hardcastle et al.,
2000, Villanueva et al., 2002, Wu et al., 2005, Monsoro-Burq et al.,
2005; Sato et al., 2005). How do we incorporate neural caudalizing
XMeis3 protein and these signaling pathways into a working model?
Our previous studies showed that XMeis3 activates FGF3 and FGF8
gene expression and that XMeis3 protein cannot induce posterior cell
fates in the absence of downstream FGF signaling in Xenopus AC
explants (Ribisi et al., 2000, Aamar and Frank, 2004). We now show
that the FGF3 and FGF8 genes are direct targets of XMeis3 protein
and that neurula stage FGF3 expression is eliminated in XMeis3
morphant embryos (Fig. 8). In this study, ectopic expression of FGF8a
partially rescued the XMeis3 morphant phenotype. Ectopic expres-
sion of either FGF8a or FGF3 mRNAs inhibited the robust anterior
expansion of anterior XANF-1 expression and rescued n-tubulin
expression. It still needs to be determined how differing doses and
timing of either FGF3 and/or FGF8 isoform activities may act
downstream of XMeis3 protein to pattern the nervous system.
However, these results suggest that XMeis3 protein induces
downstream FGF activity that acts to regulate neural patterning.
Our unpublished studies show that canonical-Wnt signaling is
required for embryonic XMeis3 expression (Elkouby and Frank).
Supporting this observation, in caudalized Xenopus explants, FGF
acted downstream to canonical Wnt signaling (Domingos et al.,
2001). RA signaling appears to additively interact with XMeis3
protein to optimalize early neurula stage Hox gene expression in
order to ﬁne tune embryonic A–P patterning (Dibner et al., 2004).
Thus, XMeis3 protein could act downstream to canonical Wnt
signaling, upstream to FGF signaling and in concert with RA signaling
to activate gene expression and thus regulate embryonic neural
caudalization (Sup. Fig. 4—model).
In future experiments, we intend to address these questions of
cellular responsiveness and competence. In our recombinant AC
explant assay system, an XMeis3 expressing AC induces hindbrain,
primary neuron (Aamar and Frank, 2004) and neural crest (unpub-
lished) markers in juxtaposed cells neuralized by the BMP DN
receptor. In this assay, we can determine if ectopic or knocked
down levels of a speciﬁc signaling pathway/s can bias the direction of
XMeis3 protein to induce speciﬁc types of posterior nervous systemcells. This manipulation of signaling pathways in explants to modify
neural cell fates may recapitulate the normal signals interacting with
XMeis3 protein in the embryo.
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